• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Pulse Biosciences, Inc.

< Previous 1 2 3 Next >
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
November 21, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
November 15, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
November 13, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call
November 10, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023
October 30, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery
October 24, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study
October 02, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit
September 29, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
September 27, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
September 07, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Clarifies Details of Recent S-3 Filing
August 24, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
August 10, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
July 27, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
May 18, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
May 11, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
May 10, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
May 03, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Announces $65 Million Private Placement
May 01, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
April 27, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
March 30, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
March 02, 2023
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Reports Third Quarter 2022 Financial Results
November 10, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022
October 27, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions
October 06, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
September 26, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
September 20, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Reports Second Quarter 2022 Financial Results
August 10, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX® System
August 04, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Schedules Second Quarter 2022 Financial Results Conference Call for August 10, 2022
July 27, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2022
From Pulse Biosciences, Inc.
Via Business Wire
Tickers PLSE
< Previous 1 2 3 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap